Cofactor Genomics
Analysis completed on 3/23/2026
Cofactor Genomics demonstrates strong technical innovation and real-world utility in the field of immunotherapy diagnostics using RNA and machine learning. However, the evaluation is heavily penalized due to low-quality, exaggerated responses in the submission, such as claiming the audience is 'everyone' and that 'most people have used my product'. While a team size of 125 suggests legitimate operational scale, the vague financial metrics and poor response quality limit the final score.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline